Evidence map›Paper›PMID 32476442›Full record

ArticleAIDS care2020

Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017.

S Ickowicz, H Dong, L Ti, S Nolan, N Fairbairn, R Barrios, M-J Milloy

Open access · greenAbstract read
In one paragraph

Article in AIDS care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

S IckowiczBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada.
H DongBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada.
L TiBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada.
S NolanBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada.
N FairbairnBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada.ORCID 0000-0002-4195-3284
R BarriosBC Centre for Excellence in HIV/AIDS, University of British Columbia, Vancouver, Canada.
M-J MilloyBritish Columbia Centre on Substance Use, St. Paul's Hospital, Vancouver, Canada.
University of British Columbia · CASt. Paul's Hospital · CA

Funding

Impacts of universal access to HIV/AIDS care among HIV+ injection drug usersU01DA021525 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI MILLOY, M-J · 2017 to 2024
$4.3M
Mentoring the next generation of addiction clinician scientists while responding to the opioid epidemicR25DA037756 · NIDA · UNIVERSITY OF BRITISH COLUMBIA · PI FAIRBAIRN, NADIA · 2014 to 2023
$3.6M
CIHRNIDA NIH HHS R25 DA037756NIDA NIH HHS U01 DA021525
6 · The paper itself

Abstract

People who use injection drugs (PWID) experience high rates of HIV acquisition and, as a result of lower rates of optimal access and adherence to combination antiretroviral therapy (ART), experience worse HIV treatment outcomes than other key affected populations. However, the incidence and risk factors for the development of AIDS among HIV-positive PWID have not been completely described. We used data from a community-recruited prospective cohort of HIV-positive PWID in Vancouver, Canada, a setting with universal no-cost ART and a comprehensive clinical monitoring registry. We used multivariable extended Cox models to identify factors associated with time to AIDS. Between 1996 and 2017, 396 participants, including 140 (35.4%) women, were followed for a median of 39.0 months (interquartile range: 16.6-76.2), among whom 165 (41.7%) developed AIDS. In a multivariable model, homelessness (Adjusted Hazard Ratio [AHR] = 1.76 (1.18-2.61)) and injection drug use within the preceding six months (AHR = 1.74 (1.17-2.58)) were independently associated with a higher risk of developing AIDS. Despite widespread scale-up of programmes to improve ART utilization, significant risk factors for the development of AIDS remain among HIV-positive PWID in this setting.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsSubstance Abuse, IntravenousCanadaFemaleHumansMalePharmaceutical PreparationsProspective StudiesRisk FactorsPharmaceutical PreparationsAIDSantiretroviral therapyHIV infectionssubstance abusetreatment outcome

Identifiers

PMID32476442
PMCPMC7530072
OpenAlexW3028927496

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.